Can lipid mediators and free fatty acids guide acute coronary syndrome diagnosis and treatment?

Creative Commons License

Uzun G., Unal A., Basarici İ., Kucuk M., Donmez L., Nacitarhan C., ...Daha Fazla

Lab Medicine, cilt.55, sa.1, ss.88-95, 2024 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 55 Sayı: 1
  • Basım Tarihi: 2024
  • Doi Numarası: 10.1093/labmed/lmad042
  • Dergi Adı: Lab Medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL
  • Sayfa Sayıları: ss.88-95
  • Anahtar Kelimeler: acute coronary syndrome, fatty acids, inflammation, lipid mediators
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Objective: The aim of this study was to investigate fatty acids, lipid mediator levels, and the desaturase index rates on different acute coronary syndrome types and their possible relationship with routine lipid parameters. Methods: The study included 81 patients with myocardial infarction (MI), 20 patients with unstable angina pectoris, and 31 healthy people. Fatty acids, CD59, lipoxin A4, 8-isoprostane, serum lipids, albumin, C-reactive protein (CRP), and high sensitive troponin levels were measured in all participants. Results: When the fatty acid groups were evaluated as a ratio of albumin, MUFA/albumin and SFA/albumin ratios were significantly higher in the MI group compared to the control group. Although CD59 and lipoxin A4 levels were higher in the control group, there was no significant differences between the groups. When lipoxin A4/CRP and CD59/CRP ratios were evaluated, the results were significantly lower than those in the control group. Conclusion: Lipid mediators may be useful in treating atherosclerosis by contributing to the resolution of inflammation.